Non Infectious Causes of Fever
Non Infectious Causes of Fever
0
CONTACT HOUR
By Gregory M. Steele, MSN, RN, FNP-BC, OCN; Carlos Franco-Paredes, MD, MPH; and
Daniel B. Chastain, PharmD, AAHIVP
ever is both a common presenting symptom one culture. However, the presence of fever is not a
F and sign identified during routine patient
care in a variety of clinical settings. In the
predictor of positive culture results. The absence of
fever is actually not a reliable predictor for the absence
outpatient and hospital settings, fever may be observed of bacteremia.2 Despite this, empiric antibiotic therapy
in up to 30% to 50% of patients, with the highest in- is commonly initiated as a result of this nonspecific
cidence among those admitted to critical care, which sign (pending additional clinical information).
may be the results of many etiologies.1,2 Fever is also a Emerging antibiotic resistance, due to overpre-
common complaint in the primary care setting, with scribing practices or poor prescribing practices, is also
approximately one-third of ambulatory care patients a major concern. In the United States, antibiotic-
reporting fever to their primary care provider (PCP).1,3 resistant pathogens were responsible for 2 million
Among hospitalized patients, documentation of illnesses and 23,000 deaths in 2011.4-6 The majority of
fever in most cases prompts the collection of at least antibiotic prescriptions are written in the outpatient
Keywords: antibiotic resistance, antibiotics, fever, infection, noninfectious fever
■ Etiology of noninfectious causes of fever traumatic brain injuries but occurs less commonly in
Rheumatic diseases, including vasculitis, connective ischemic stroke.2,14 Compared with fevers caused by
tissue diseases, and granulomatous diseases, may be infections, central fever occurs earlier and lasts longer
responsible for fever in up to 30% of patients with with higher temperatures.
fever of unknown origin.11,12 Consequently, pyrogenic Confirming the diagnosis of central fever remains
cytokines play a direct role in temperature elevation, a challenge.14 In the setting of negative cultures, chest
as described above, while also modifying hepatic pro- radiographs, and fever onset within 3 days, the prob-
tein synthesis, including increasing: C-reactive protein, ability of central fever is high. Empirical antimicrobial
serum amyloid A, ceruloplasmin, alpha-1-antitrypsin, therapy is often initiated early in these patients but
haptoglobin, fibrinogen, and C1 inhibitors; pyrogenic should promptly be discontinued if the cultures and
cytokines also decrease transferrin, albumin, and fi- chest radiographs are negative. Treatment should be
bronectin, many of which are tests performed during directed at lowering body temperature through intra-
routine workup.12 vascular or surface cooling devices.
Initial workup should include a thorough exam Thomboembolism. Venous thromboembolism
of mucous membranes, eyes, lymph nodes, temporal (VTE) has been identified as a noninfectious cause of
arteries, liver, spleen, and skin in addition to anti- fever.15 Vascular damage initiates the coagulation pro-
nuclear antibody and rheumatoid factor testing.11 cess.16 Recruitment of inflammatory cells, growth
Although the antinuclear antibody and rheumatoid factors, and cytokines, including ILs, TNF-alpha, and
factor are sensitive, they lack specificity, and are there- IFN-gamma, soon follows.17 Although the precise
fore most useful in confirming a clinical diagnosis. mechanism of fever has not been described, fever
Importantly, bacterial, mycobacterial, and fungal associated with a pulmonary embolism (PE) and
cultures must be obtained to rule out infectious deep vein thrombosis (DVT) are likely the result of
etiologies. Diagnostic imaging may be of benefit, par- a complex interaction between direct vascular irrita-
ticularly in patients with positive rheumatologic test- tion, inflammatory cytokines, tissue necrosis, and
ing. Confirming or excluding a diagnosis may require hemorrhage.18
invasive diagnostics with lymph node, tissue, or bone Most often, fever is due to a PE but has also been
marrow biopsies.11,13 observed with DVT.18 Signs and symptoms are com-
Intracranial hemorrhage/ischemic stroke. Central monly observed in these patients.19 Typically, fever
fever occurs in up to 70% of patients admitted with associated with VTE is low grade (less than 100.9° F
neurologic conditions.14 Alterations in body tempera- [38.3° C]) but rarely greater than 102° F (38.9° C) and
ture are due to the loss of hypothalamic control. Central occurs for a short duration. Rates of fever are similar
fever is likely in patients with subarachnoid hemor- in patients with or without pulmonary hemorrhage
rhages, intraventricular hemorrhages, brain tumors, or or infarction.20 Initiation of anticoagulation resolves
fever, but higher mortalities persist compared with membranes in the exudative phase; approximately 7
those without fever. days later, the proliferative phase begins with develop-
Aspiration pneumonitis. Inhalation of oropharyn- ment of pulmonary fibrosis and interstitial inflamma-
geal or gastric contents into the lungs may lead to a tion.25 Although most patients recover within 21 days,
variety of syndromes, including chemical pneumonitis, some advance to the fibrotic stage, which is character-
primary bacterial aspiration pneumonia, or secondary ized by worsening fibrosis and bullae formation.
bacterial infection following chemical pneumonitis.21 An ARDS diagnosis is based on the presence of
Large volume (greater than 0.3 mL/kg of body weight hypoxemia in the setting of bilateral or alveolar inter-
or 20 to 25 mL in adults) aspiration of acidic gastric stitial infiltrates occurring within 7 days of insult
contents (pH less than 2.5) is required to cause chemi- (known collectively as the Berlin definition).24,26 Clini-
cal pneumonitis.22 cal features observed in ARDS may mimic a variety of
Subsequently, corrosive damage
to the alveolar cells occurs followed
by neutrophil invasion with con- Inhalation of oropharyngeal or gastric contents
comitant release of proinflammatory into the lungs may lead to chemical pneumonitis
cytokines. Due to gastric acid inhib- or bacterial aspiration pneumonia.
iting bacterial growth, gastric con-
tents are typically sterile. Secondary
bacterial infections occur more frequently in patients other noninfectious diseases, including interstitial
receiving gastric acid suppressing medications. pneumonia, eosinophilic pneumonia, bronchiolitis
Symptom onset, fever, hypoxia, dyspnea, and cough obliterans organizing pneumonia, diffuse alveolar
occur rapidly within hours following aspiration.22 Ra- hemorrhage, hypersensitivity pneumonitis, and car-
diographic imaging reveals pulmonary infiltrates in the diogenic pulmonary edema.27
dependent portions of the lungs depending on patient Identification of the underlying condition is more
positioning. Clinical and radiographic improvement vital than incorrectly identifying an infectious pneu-
occurs quickly (within days) in the majority of patients, monia as the cause of respiratory failure, as no specific
whereas some rapidly develop respiratory failure and drug therapy exists for ARDS. Treatment is supportive
acute respiratory distress syndrome (ARDS). with noninvasive or mechanical ventilation with low
Initial improvement is followed by clinical deterio- tidal volumes, fluid conservation, and managing the
ration in a small subset of patients who develop secondary underlying condition.
bacterial infection following chemical pneumonitis. Blood product transfusion. Approximately 90% of
Treatment primarily revolves around supportive care critically ill patients in ICUs are anemic, and 40% of
involving patient repositioning and pulmonary care; these receive a transfusion during their hospitalization
however, empirical antibiotics are frequently started.21 (accounting for the 15 million units transfused annu-
Early discontinuation of antibiotics is indicated in ally).28 Although benefits are obvious, transfusions and
patients experiencing rapid clinical improvement and therapeutic plasma exchange may result in acute or
in those with negative or contaminated microbiologic delayed reactions, including allergic, acute, or delayed
samples. hemolytic transfusion reaction; febrile nonhemolytic
ARDS. Refractory hypoxemia is the hallmark of transfusion reaction; acute lung injury; circulatory
ARDS.23 Increased alveolar permeability and collapse overload; graft versus host disease; iron overload;
develop following direct or indirect lung injury, includ- or infections.28-30 No specific signs or symptoms are
ing aspiration of gastric contents; lung contusion or able to differentiate transfusions, and therapeutic
trauma; inhalation of toxic substances; drug overdose; plasma exchange related reactions from other medical
transfusions; or infectious pneumonia. The progression problems.
of ARDS is characterized by three distinct phases.24 Transfusion and therapeutic plasma exchange related
Alveolar edema, in addition to proinflammatory and reactions typically occur within 24 hours but as soon as
pyrogenic cytokines within the interstitial and alveolar 15 minutes following completion (depending on sever-
spaces, recruits neutrophils, which causes further al- ity).28-30 Fever, chills, pruritus, hives, hypotension, and
veolar damage with subsequent development of hyaline respiratory distress are observed most frequently. Clinical
assessment and patient history in combination with in- Urgent surgical management via cholecystectomy or
formation obtained from blood bank personnel are vital percutaneous cholecystostomy is required.
to distinguishing transfusion and therapeutic plasma Thyroid storm. Excessive release of thyroid hor-
exchange related reactions from infections. mones yields a hypermetabolic state known as thyroid
Acute pancreatitis. Pancreatic enzyme activation storm.41 Although rare, thyroid storm usually follows
leads to autodigestion of the pancreas with resultant a precipitating event, such as surgery, anesthesia, trau-
inflammation, which is known as acute pancreatitis.31 ma, high doses or withdrawal of thyroid hormone,
Etiologies of acute pancreatitis are dominated by iodinated contrast, or amiodarone. Signs and symp-
gallstones and alcohol abuse followed by hypertriglyc- toms may mimic those observed in infections, such as
eridemia, drugs, pancreatic strictures, and rarely, infec- tachycardia and fever (including hyperpyrexia) due to
tions.32-34 Patients generally present with acute onset, adrenergic activation.
epigastric pain that may radiate to the back with ac- No universally validated criteria or tools currently
companying nausea and vomiting. Physical findings exist for diagnosing thyroid storm except for a scoring
may include fever, tachypnea, hypotension, and hy- system developed by Burch and Wartofsky in 1993.41,42
poxemia depending on severity. As a result, clinical features are the focus of diagnosis
Diagnosis of acute pancreatitis requires two of the rather than lab abnormalities, which are comparable
following three criteria: characteristic abdominal pain, to those found in hyperthyroidism. Prompt multifac-
serum amylase or lipase at least three times the upper eted treatment aimed at decreasing adrenergic activa-
limit of normal, and inflammatory changes visualized tion, as well as blocking thyroid hormone production,
on computed tomography (CT) scan.31,32 Historically, secretion, and systemic activation, is required due to
uncontrolled studies suggested antimicrobial therapy high mortalities.41,43
may decrease infection and mortalities, but random- Crystal-induced arthropathies. Gout, a metabolic
ized, double-blind, placebo-controlled trials refute this disease, is characterized by hyperuricemia resulting
recommendation.35-37 Antibiotics should be withheld from diets high in purines, alcohol consumption, di-
regardless of type or severity of pancreatic disease uretic therapy, and impaired renal elimination.44,45
unless a confirmed infection is documented.38 Approximately 1% to 2% of adults in the developed
world and 4% in the United States
are affected by gout, with higher
Although the mechanism is not fully rates in males and increasing inci-
understood, drug fever may be the result dence until 70 years of age.45 Acute
of hypersensitivity reactions. gouty arthritis may mimic infectious
conditions, and therefore, should be
considered in the differential diag-
Acalculous cholecystitis. Acalculous cholecystitis nosis of individuals presenting with fever, pain, ery-
results from biliary stasis rather than gallstones or thema, and swelling—particularly around single or
biliary sludge occluding the cystic duct as observed in multiple joints.44,45 Inflammation typically accompa-
acute cholecystitis.39,40 Risk factors for developing acal- nies cellulitis and acute gouty arthritis, which focuses
culous cholecystitis include sepsis, trauma, burns, around a joint in the latter condition. Although mono-
surgery, total parenteral nutrition, and even chronic articular involvement may cause difficulty in distin-
diseases such as diabetes mellitus, cardiovascular dis- guishing it from septic arthritis, joint aspiration with
ease, and end-stage renal disease. Gallbladder stasis subsequent identification of urate crystals by polarized
and distension lead to endothelial injury, inflamma- microscopy should confirm gout.46
tion, and subsequent necrosis, which may result in Drug-induced fever. While frequently cited as the
perforation. cause of fever in clinical practice, drug fever is the true
Clinical manifestations, such as fever, right upper cause of fever in a mere 3% to 5% of cases, with in-
quadrant pain, nausea, and vomiting, are nonspecific creased risk directly correlated with number of drugs
and often indistinguishable from calculous cholecys- prescribed.47 Published cases are extremely heteroge-
titis.38,39 Abdominal ultrasound or CT scan may reveal neous and identify numerous drugs as the ultimate
gallbladder distension without evidence of gallstones. cause (but most frequently, antibiotics, antiepileptics,
and antiarrhythmics). Although the mechanism is not clues of noninfectious causes of fever. Suspicion for
fully understood, drug fever may be the result of hy- an alternate diagnosis without clinical signs of sepsis
persensitivity reactions, including a drug reaction with should cause the APP to not initiate antibiotic therapy
eosinophilia and systemic symptoms syndrome, ther- until a diagnosis is firmly established.
moregulatory alterations, or idiosyncratic reactions.48
REFERENCES
Unfortunately, due to a common misconception
1. Dekker AR, Verheij TJ, van der Velden AW. Inappropriate antibiotic pre-
that all fevers are the result of infectious etiologies, an scription for respiratory tract indications: most prominent in adult patients.
extensive workup with additional blood cultures, ra- Fam Pract. 2015;32(4):401-407.
2. Niven DJ, Laupland KB. Pyrexia: aetiology in the ICU. Crit Care. 2016;20:247.
diographic studies, and a variety of antibiotic agents is
3. Schroeck JL, Ruh CA, Sellick JA Jr, Ott MC, Mattappallil A, Mergenhagen KA.
frequently pursued, which prolongs hospitalization.47 Factors associated with antibiotic misuse in outpatient treatment for upper re-
spiratory tract infections. Antimicrob Agents Chemother. 2015;59(7):3848-3852.
As a result, drug fever is typically a diagnosis of exclu-
4. Hicks LA, Bartoces MG, Roberts RM, et al. US outpatient antibiotic pre-
sion when fever persists. scribing variation according to geography, patient population, and provider
Fever commonly occurs 7 to 10 days after initia- specialty in 2011. Clin Infect Dis. 2015;60(9):1308-1316.
5. Sanchez GV, Hersh AL, Shapiro DJ, Cawley JF, Hicks LA. Outpatient anti-
tion of the causative agent but may be drug-specific biotic prescribing among United States nurse practitioners and physician
and occur at any time. No specific fever pattern has assistants. Open Forum Infect Dis. 2016;3(3):ofw168.
6. Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic
been identified, but the degree of pyrexia could vary prescribing in primary care on antimicrobial resistance in individual pa-
while presenting as continuous, remittent, intermit- tients: systematic review and meta-analysis. BMJ. 2010;340:c2096.
tent, or hectic. 48 Nonspecific lab abnormalities, 7. O’Grady NP, Barie PS, Bartlett JG, et al; American College of Critical Care
Medicine; Infectious Diseases Society of America. Guidelines for evaluation
including leukocytosis with eosinophilia, elevated of new fever in critically ill adult patients: 2008 update from the American
College of Critical Care Medicine and the Infectious Diseases Society of
erythrocyte sedimentation rate, or transaminitis, America. Crit Care Med. 2008;36(4):1330-1349.
could be present. 8. Commission for Thermal Physiology of the International Union of Physi-
ological Sciences (IUPS Thermal Commission). Glossary of terms for
If drug fever is suspected, the most likely offending thermal physiology (3rd ed.). Jpn J Physiol. 2001;51:245-280.
agent should be discontinued first followed by other 9. Dinarello CA. Infection, fever, and exogenous and endogenous pyrogens:
probable drugs if fevers continue.47 Fever cessation some concepts have changed. J Endotoxin Res. 2004;10(4):201-222.
10. Dinarello CA. Thermoregulation and the pathogenesis of fever. Infect Dis
should occur within 72 hours but may take weeks if Clin North Am. 1996;10(2):433-449.
accompanied by cutaneous manifestations. 11. Mulders-Manders CM, Simon A, Bleeker-Rovers CP. Rheumatologic diseases
as the cause of fever of unknown origin. Best Pract Res Clin Rheumatol.
2016;30(5):789-801.
■ Treatment of fever and hyperthermia 12. Tóth E, Speer G. Febrile conditions in rheumatology. Clin Rheumatol. 2012;
Increased body temperature may result in physiologic 31(12):1649-1656.
13. Cunha BA, Lortholary O, Cunha CB. Fever of unknown origin: a clinical
stress.2,8,9 In patients with hyperthermia, body tem- approach. Am J Med. 2015;128(10):1138.e1-1138.e15.
perature must be rapidly decreased, whereas the ben- 14. Hocker SE, Tian L, Li G, Steckelberg JM, Mandrekar JN, Rabinstein AA. In-
dicators of central fever in the neurologic intensive care unit. JAMA Neurol.
eficial effects of antipyretics to lower temperature in 2013;70(12):1499-1504.
febrile patients are of considerable debate. Acetamino- 15. Arnow PM, Flaherty JP. Fever of unknown origin. Lancet. 1997;350(9077):
phen and nonsteroidal anti-inflammatory drugs are 575-580.
16. Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med. 2008;
efficacious in reducing fever while also limiting the 359(9):938-949.
associated physiologic effects but may lead to un- 17. Sprague AH, Khalil RA. Inflammatory cytokines in vascular dysfunction and
vascular disease. Biochem Pharmacol. 2009;78(6):539-552.
wanted adverse reactions.2 Although treating fever
18. Barba R, Di Micco P, Blanco-Molina A, et al. Fever and deep venous thrombosis.
may improve outcomes, attempts to identify the etiol- Findings from the RIETE registry. J Thromb Thrombolysis. 2011;32(3):288-292.
ogy of the increased body temperature are of most 19. Rehman T, deBoisblanc BP. Persistent fever in the ICU. Chest. 2014;145(1):
158-165.
importance.
20. Stein PD, Afzal A, Henry JW, Villareal CG. Fever in acute pulmonary embo-
lism. Chest. 2000;117(1):39-42.
■ Conclusions 21. Raghavendran K, Nemzek J, Napolitano LM, Knight PR. Aspiration-induced
lung injury. Crit Care Med. 2011;39(4):818-826.
APPs are a steadily growing segment of the PCP popu- 22. Marik PE. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med.
lation, and therefore, frequently encounter patients 2001;344(9):665-671.
presenting with fever as a cardinal sign in their prac- 23. Koh Y. Update in acute respiratory distress syndrome. J Intensive Care. 2014;
2(1):2.
tice. While fever is a sign that can certainly be indicative 24. ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT,
of an infectious process, it is important for the APP to et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA.
2012;307(23):2526-2533.
consider fever of noninfectious origin. A detailed his- 25. Parsons PE, Eisner MD, Thompson BT, et al; NHLBI Acute Respiratory
tory and physical exam often provide sufficient clinical Distress Syndrome Clinical Trials Network. Lower tidal volume ventilation
and plasma cytokine markers of inflammation in patients with acute lung 38. Tenner S, Baillie J, DeWitt J, Vege SS. American College of Gastroenterol-
injury. Crit Care Med. 2005;33(1):1-6. ogy guideline: management of acute pancreatitis. Am J Gastroenterol.
26. Ferguson ND, Fan E, Camporota L, et al. The Berlin definition of ARDS: 2013;108(9):1400-1415,1416.
an expanded rationale, justification, and supplementary material. Intensive 39. Treinen C, Lomelin D, Krause C, Goede M, Oleynikov D. Acute acalculous
Care Med. 2012;38(10):1573-1582. cholecystitis in the critically ill: risk factors and surgical strategies. Langen-
27. Schwarz MI, Albert RK. “Imitators” of the ARDS: implications for diagnosis becks Arch Surg. 2015;400(4):421-427.
and treatment. Chest. 2004;125(4):1530-1535. 40. Knab LM, Boller AM, Mahvi DM. Cholecystitis. Surg Clin North Am. 2014;
28. Long B, Koyfman A. Red blood cell transfusion in the Emergency Depart- 94(2):455-470.
ment. J Emerg Med. 2016;51(2):120-130. 41. Chiha M, Samarasinghe S, Kabaker AS. Thyroid storm: an updated review.
29. Carson JL, Guyatt G, Heddle NM, et al. Clinical Practice Guidelines from J Intensive Care Med. 2015;30(3):131-140.
the AABB: red blood cell transfusion thresholds and storage. JAMA. 42. Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Thyroid storm.
2016;316(19):2025-2035. Endocrinol Metab Clin North Am. 1993;22(2):263-277.
30. Basic-Jukic N, Kes P, Glavas-Boras S, Brunetta B, Bubic-Filipi L, Puretic Z. 43. Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association
Complications of therapeutic plasma exchange: experience with 4857 treat- Guidelines for diagnosis and management of hyperthyroidism and other
ments. Ther Apher Dial. 2005;9(5):391-395. causes of thyrotoxicosis. Thyroid. 2016;26(10):1343-1421.
31. Muniraj T, Gajendran M, Thiruvengadam S, Raghuram K, Rao S, Devaraj P. 44. Richette P, Bardin T. Gout. Lancet. 2010;375(9711):318-328.
Acute pancreatitis. Dis Mon. 2012;58(3):98-144. 45. Dalbeth N, Merriman TR, Stamp LK. Gout. Lancet. 2016;388(10055):2039-2052.
32. Banks PA, Bollen TL, Dervenis C, et al; Acute Pancreatitis Classification Work- 46. Qaseem A, McLean RM, Starkey M, Forciea MA; Clinical Guidelines Com-
ing Group. Classification of acute pancreatitis--2012: revision of the Atlanta mittee of the American College of Physicians. Diagnosis of acute gout:
classification and definitions by international consensus. Gut. 2013;62(1): A Clinical Practice Guideline from the American College of Physicians.
102-111. Ann Intern Med. 2017;166(1):52-57.
33. Badalov N, Baradarian R, Iswara K, Li J, Steinberg W, Tenner S. Drug- 47. Patel RA, Gallagher JC. Drug fever. Pharmacotherapy. 2010;30(1):57-69.
induced acute pancreatitis: an evidence-based review. Clin Gastroenterol
Hepatol. 2007;5(6):648-661; quiz 644. 48. Johnson DH, Cunha BA. Drug fever. Infect Dis Clin North Am. 1996;10(1):85-91.
34. Larson SD, Nealon WH, Evers BM. Management of gallstone pancreatitis. Gregory M. Steele is a family NP with Phoebe Infectious Diseases, Phoebe
Adv Surg. 2006;40:265-284. Putney Memorial Hospital, Albany, Ga.
35. Dellinger EP, Tellado JM, Soto NE, et al. Early antibiotic treatment for Carlos Franco-Paredes is an associate professor of Medicine in the Division of
severe acute necrotizing pancreatitis: a randomized, double-blind, placebo- Infectious Diseases at the University of Colorado, Anschutz Medical Center,
controlled study. Ann Surg. 2007;245(5):674-683. Aurora, Colo.
36. Isenmann R, Rünzi M, Kron M, et al. German Antibiotics in Severe Acute
Daniel B. Chastain is a clinical assistant professor at the University of Georgia,
Pancreatitis Study Group. Prophylactic antibiotic treatment in patients with
College of Pharmacy, Department of Clinical and Administrative Pharmacy,
predicted severe acute pancreatitis: a placebo-controlled, double-blind trial.
Albany, Ga.
Gastroenterology. 2004;126(4):997-1004.
37. García-Barrasa A, Borobia FG, Pallares R, et al. A double-blind, placebo- The authors and planners have disclosed no financial relationships related to
controlled trial of ciprofloxacin prophylaxis in patients with acute necrotiz- this article.
ing pancreatitis. J Gastrointest Surg. 2009;13(4):768-774. DOI-10.1097/[Link].0000531067.65817.7d
INSTRUCTIONS
Noninfectious causes of fever in adults
TEST INSTRUCTIONS DISCOUNTS and CUSTOMER SERVICE
• To take the test online, go to our secure website at www. • Send two or more tests in any nursing journal published by
[Link]/ce/NP. View instructions for taking the Lippincott Williams & Wilkins together and deduct $0.95 from the
test online there. price of each test.
• If you prefer to submit your test by mail, record your an- • We also offer CE accounts for hospitals and other healthcare facilities
swers in the test answer section of the CE enrollment form on [Link]. Call 1-800-787-8985 for details.
on page 45. You may make copies of the form.
Each question has only one correct answer. There is no PROVIDER ACCREDITATION
minimum passing score required. Lippincott Professional Development will award 1.0 contact hour for this
Complete the registration information and course evalua- continuing nursing education activity.
tion. Mail the completed form and registration fee of $12.95 Lippincott Professional Development is accredited as a provider of
to: Lippincott Professional Development CE Group, 74 Brick continuing nursing education by the American Nurses Credentialing
Blvd., Bldg. 4, Suite 206, Brick, NJ 08723. We will mail your Center’s Commission on Accreditation.
certificate in 4 to 6 weeks. For faster service, include a fax This activity is also provider approved by the California Board of
number and we will fax your certificate within 2 business Registered Nursing, Provider Number CEP 11749 for 1.0 contact hour.
days of receiving your enrollment form. You will receive Lippincott Professional Development is also an approved provider of
your CE certificate of earned contact hours and an answer continuing nursing education by the District of Columbia, Georgia,
key to review your results. and Florida CE Broker #50-1223.
• Registration deadline is March 6, 2020.